Dr. Michael Hurwitz, MD, MPH, MsC
Claim this profileGSK Investigational Site
Studies Ovarian Cancer
Studies Non-Small Cell Lung Cancer
8 reported clinical trials
17 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
HLA-A positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Michael Hurwitz, MD, MPH, MsC is currently running
LYL797
for Breast and Lung Cancer
This trial is testing a new treatment called LYL797, which uses modified immune cells to target and kill hard-to-treat breast and lung cancer cells. The study aims to find a safe dose and see how well it works in patients whose cancers have not responded to other treatments.
Recruiting1 award Phase 17 criteria
Radium-223 + Docetaxel
for Prostate Cancer
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Recruiting2 awards Phase 323 criteria
More about Michael Hurwitz, MD, MPH, MsC
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Michael Hurwitz, MD, MPH, MsC has experience with
- LYL797
- ATL001
- Pembrolizumab
- GSK3901961
- GSK4427296
- GSK3845097
Breakdown of trials Michael Hurwitz, MD, MPH, MsC has run
Ovarian Cancer
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Hurwitz, MD, MPH, MsC specialize in?
Michael Hurwitz, MD, MPH, MsC focuses on Ovarian Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Michael Hurwitz, MD, MPH, MsC currently recruiting for clinical trials?
Yes, Michael Hurwitz, MD, MPH, MsC is currently recruiting for 5 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Michael Hurwitz, MD, MPH, MsC has studied deeply?
Yes, Michael Hurwitz, MD, MPH, MsC has studied treatments such as LYL797, ATL001, Pembrolizumab.
What is the best way to schedule an appointment with Michael Hurwitz, MD, MPH, MsC?
Apply for one of the trials that Michael Hurwitz, MD, MPH, MsC is conducting.
What is the office address of Michael Hurwitz, MD, MPH, MsC?
The office of Michael Hurwitz, MD, MPH, MsC is located at: GSK Investigational Site, New Haven, Connecticut 06504 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.